Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension

Ocular Hypertension (OHT) Clinical Trial

Official title:
A Prospective, Randomized, Controlled Clinical Feasibility Investigation of the Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects

Status Terminated

Clinical Trial Summary

The primary purpose of this study is to investigate the safety and efficacy of bilateral DWT in subjects with POAG or OHT compared to active and sham controls. The secondary purpose of the study is to investigate the durability, repeatability, and does response of the same.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02226094
Study type	Interventional
Source	OcuTherix, Inc.
Contact
Status	Terminated
Phase	Phase 1/Phase 2
Start date	November 2013
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02565173` - Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma	Phase 3
Recruiting	`NCT06016972` - Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients	Phase 2
Completed	`NCT01318252` - AL-54478 Proof of Concept Study	Phase 2
Terminated	`NCT01180062` - Safety Study of Latanoprost Slow Release Insert	Phase 1
Completed	`NCT01917383` - A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma	Phase 2
Completed	`NCT01670266` - Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma	Phase 1
Completed	`NCT02829996` - Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG	Phase 2
Recruiting	`NCT06249152` - Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients	Phase 2